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In vitro and ex vivo experiments indicate that elastase-2 (ELA-2), a chymotrypsin-serine
protease elastase family member 2A, is an alternative pathway for angiotensin II (Ang
II) generation. However, the role played by ELA-2 in vivo is unclear. We examined
ELA-2 knockout (ELA-2KO) mice compared to wild-type (WT) mice and determined
whether ELA-2 played a role in hemodynamics [arterial pressure (AP) and heart rate
(HR)], cardiocirculatory sympathovagal balance and baroreflex sensitivity. The variability
of systolic arterial pressure (SAP) and pulse interval (PI) for evaluating autonomic
modulation was examined for time and frequency domains (spectral analysis), whereas
a symbolic analysis was also used to evaluate PI variability. In addition, baroreflex
sensitivity was examined using the sequence method. Cardiac function was evaluated
echocardiographically under anesthesia. The AP was normal whereas the HR was
reduced in ELA-2KO mice (425 ± 17 vs. 512 ± 13 bpm from WT). SAP variability and
baroreflex sensitivity were similar in both strains. The LF power from the PI spectrum
(33.6 ± 5 vs. 51.8 ± 4.8 nu from WT) and the LF/HF ratio (0.60 ± 0.1 vs. 1.45 ± 0.3
from WT) were reduced, whereas the HF power was increased (66.4 ± 5 vs. 48.2 ± 4.8
nu from WT) in ELA-2KO mice, indicating a shift toward parasympathetic modulation
of HR. Echocardiographic examination showed normal fractional shortening and an
ejection fraction in ELA-2KO mice; however, the cardiac output, stroke volume, and
ventricular size were reduced. These findings provide the first evidence that ELA-2 acts
on the sympathovagal balance of the heart, as expressed by the reduced sympathetic
modulation of HR in ELA-2KO mice.
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INTRODUCTION
The beneficial effects of angiotensin-converting enzyme
(ACE) inhibitors in the treatment of arterial hypertension,
congestive heart failure, and other cardiovascular diseases
are well documented (Hansson et al., 1999; Jorde et al., 2000;
Yusuf et al., 2000; Lindholm et al., 2002; Jandeleit-Dahm
et al., 2005; Feldstein, 2014; Te Riet et al., 2015). However,
patients chronically treated with appropriate doses of ACE
inhibitors do not show permanent attenuation of angiotensin
II (Ang II) plasma levels (Jorde et al., 2000; Farquharson and
Struthers, 2002), indicating the existence of an ACE-independent
alternative pathway for Ang II generation. Elastase-2 (ELA-2), a
chymotrypsin-serine protease elastase family member 2A, is an
alternative Ang II generator. This enzyme is widely distributed
in several murine organs, such as the lung, pancreas, liver, heart,
kidney, and blood vessels (Santos et al., 2002; Becari et al., 2011).
The functional role of ELA-2 for Ang II generation was
demonstrated in both in vitro and ex vivo mesenteric arterial
beds (Santos et al., 2002, 2003), hearts and carotid arteries (Becari
et al., 2005, 2011). However, the in vivo role of ELA-2 remains
unclear, and there are no reports providing support for its
participation in cardiocirculatory regulation under physiological
conditions. Thus, to investigate whether ELA -2 plays a role in
cardiocirculatory regulation, our laboratory developed a knock-
out mouse strain for the ELA-2 gene (ELA-2KO).
This study hypothesized that ELA-2 may have a significant
contribution in cardiocirculatory regulation due to its wide tissue
distribution. Therefore, knock out mice were used to examine
changes in cardiovascular parameters (arterial pressure and heart
rate) and sympathovagal balance that may be associated with
the lack of ELA-2. To test this hypothesis, the cardiocirculatory
sympathovagal balance was examined in the time and frequency
domains and the baroreflex function, assessed by baroreflex
sensitivity, was investigated in conscious ELA-2KO andwild-type
mice (Bertinieri et al., 1985; Di Rienzo et al., 2001). Moreover, a
nonlinear method for investigating heart rate variability (HRV),
based on symbolic analysis, was also applied (Guzzetti et al.,
2005a; Porta et al., 2007). Additionally, cardiac function was
evaluated using echocardiography to assess the cardiac output,
stroke volume, fractional shortening, ejection fraction, and
ventricular dimension in anesthetized ELA-2KO mice. Cardiac
morphological aspects, such as myocyte size, cardiac index,
ventricular area, ventricular wall thickness, and collagen density
were also studied histologically.
Given the potential for future research in this field, the aim
of this study was to investigate the role of tissue ELA2 in the
control of hemodynamics and cardiac function by characterizing
cardiocirculatory sympathovagal balance, baroreflex sensitivity,
and cardiac physiological parameters in ELA-2KO mice.
METHODS
Ethical Approved
All studies involving animals are reported in accordance with the
ARRIVE guidelines (Kilkenny et al., 2010; McGrath et al., 2010,
2015). All procedures were approved by the Ethics Committee
in Animal Research of the Ribeirão Preto Medical School
(University of São Paulo, Ribeirão Preto, SP, Brazil; Protocol #
058/2012).
Animals
Experiments were performed using wild-type (WT) male mice
(C57Bl/6J) and ELA-2 KOmice (Cela2aTm1Bdr). Their age ranged
from 10 to 15 weeks and weighed from 25 to 32 g. ELA-2KO and
WT mice were supplied, respectively, by Dr. Helio C. Salgado’s
Laboratory and the Animal Facility of the University of Sao Paulo
in Ribeirao Preto (SP, Brazil). Mice were fed standard chow diet
and tap water ad libitum and were housed under controlled
temperature (22◦C) and 12-h dark-light cycles.
ELA-2 Knockout Homozygous Mice
ELA-2KO (B6;129P2-Cela2aTm1Bdr) mice were developed as
described in the Supplemental Data.
Genotyping
Tail tissue genomic DNA was obtained and was used to amplify
the target gene by polymerase chain reaction (PCR). The
expected amplicon size for the knockout allele amplified with
the primers ElaF (5′AGAAACTATGTCTGCTATGTCAC3′) and
pELAloxr2 (5′TTCTTGAACTGATGGCGAGC3′) is 295 bp, and
the WT allele should yield an amplicon of 345 bp using the
primers ElaF and Ela WTR (5′TTTACAGATGAGGAAGTC
ACC3′).
Echocardiography
The mice were lightly anesthetized with 1.5% isoflurane in 100%
O2. The chest wall was shaved, and a small gel standoff was
placed between the chest and a 30-MHz scan head interfaced with
a Vevo 2100 High-Resolution Imaging System (VisualSonics,
Toronto, ON, Canada). The body temperature was monitored
during echocardiography. High-resolution B mode and M mode
images were acquired with a 30-MHz transducer. Continuous,
standard electrocardiography was recorded using electrodes
placed on the animal’s extremities. Systolic measurements
were recorded at the point of minimal cavity dimension
using the leading edge method of the American Society of
Echocardiography. Ejection fraction and fractional shortening
were calculated and used as the determinant of left ventricle
systolic function.
Catheter Implantation
Mice were anesthetized with isoflurane (5% for induction and
2–3% for maintenance) provided by an isoflurane vaporizer
(Calibrated Vaporizer Takaoka, model ISOVAPOR 1224, K.
Takaoka Ind. Com. Ltda., São Paulo, Brazil). An arterial catheter
composed of Micro-Renathane tubing (0.64-mm outer diameter,
0.30-mm inner diameter; Braintree Scientific, Braintree, MA,
USA) was chronically implanted into the femoral artery
for arterial pressure measurement. The catheter was filled
with heparinized saline (100 i.u. ml−1), capped, tunneled
subcutaneously and exposed on the back of the neck. Mice
received penicillin/streptomycin (200 i.u. g−1 and 80µg g−1,
respectively) and were allowed to recover for 4 days.
Frontiers in Physiology | www.frontiersin.org 2 March 2017 | Volume 8 | Article 170
Becari et al. Cardiovascular Profile of Elastase-2 Knockout Mice
Arterial Pressure and Heart Rate
Experiments were performed in conscious unrestrained mice,
in their own cages, 4 days after surgery. On the day of the
experiment, the arterial catheter was connected to a pressure
transducer (model DPT-100 Deltran R©; Utah Medical Products,
Midvale, UT, USA) and mice were allowed to rest for 30–45 min.
The basal arterial pressure and heart rate signals were recorded
continuously for 30 min to evaluate the arterial pressure, pulse
interval variability and baroreflex sensitivity. Data acquisition
was performed using the Dataquest ARTTM System software
(Data Sciences International, St. Paul, MN) at a sample frequency
of 2 kHz. All experiments were performed during the daytime to
avoid any interference from circadian rhythms.
Pulsatile arterial pressure was analyzed using specific software
that detects inflection points in periodic waves (LabChart version
7.0; AD Instruments, Sydney, Australia). A beat-by-beat time
series of systolic arterial pressure (SAP) was generated. A series of
pulse intervals was obtained by measuring the intervals between
consecutive arterial pressure values, which were used to measure
HRV.
Arterial Pressure and Pulse Interval variability
The baseline SAP and pulse interval were used for variability
analysis using customized software (CardioSeries-version 2.4,
http://sites.google.com/site/cardioseries). For measures on the
time domain, the standard deviation (SD) of successive normal
values of the pulse interval (SDNN) and square root of the mean
of the sum of the square of differences between adjacent pulse
intervals (RMSSD) were considered. The overall variability of
the arterial pressure was also calculated using the SD of the
SAP series. The arterial pressure and pulse interval variability
were also studied in the frequency domain by spectral analysis.
The time series of the SAP and pulse interval were resampled
to 12 Hz by cubic spline interpolation and were divided into
contiguous segments of 512 values, which overlapped by 50%.
Using a Hanning window, the spectrum of each segment of either
the SAP or pulse interval series was calculated using the fast
Fourier transformmethod and was integrated into two frequency
bands: low frequency (LF; 0.1–1Hz) and high frequency (HF; 1–5
Hz). The results are expressed in absolute units (ms2 or mmHg2)
and normalized units (nu). The HRV was used to investigate the
relative cardiac autonomic modulation from the sympathetic (LF
power) and parasympathetic (HF power) systems in humans and
rodents. The ratio of LF to HF (LF/HF) was used to represent the
sympathovagal balance (Thireau et al., 2008; Thayer et al., 2010).
Symbolic Analysis
To distinguish between sympathetic and parasympathetic cardiac
modulation, symbolic analysis of three-beat sequences was
performed using customized software (CardioSeries version 2.4,
http://sites.google.com/site/cardioseries) to detect changes in
autonomic modulation (Guzzetti et al., 2005b; Porta et al., 2007).
Pulse interval sequences of ∼60 s were selected from continuous
basal recordings. The full range of sequences was uniformly
spread across six levels (from 0 to 5), transforming them into
a sequence of integers (i.e., symbols). Patterns, represented by
sequences of three symbols, were constructed based on the
sequence of symbols, and all possible patterns were divided into
the following four groups (Guzzetti et al., 2005b):
1. Patterns with no variations (0 V; three symbols equal,
indicating sympathetic modulation);
2. Patterns with one variation (1 V; two consequent symbols
equal and the remaining symbol was different, indicating both
sympathetic and parasympathetic modulation);
3. Patterns with two similar variations (2 LV; three symbols
forming an ascending or a descending ramp, indicating
parasympathetic modulation);
4. Patterns with two dissimilar variations (2 UV; the three
symbols forming a peak or valley, indicating parasympathetic
modulation);
The rates of occurrence of these patterns (0 V, 1 V, 2 LV, and 2
UV) were quantified. Approximately 12 series of pulse intervals
of 60 s each were used for each animal.
Spontaneous Baroreflex Sensitivity
Spontaneous baroreflex sensitivity was assessed using the
sequence technique described by Bertinieri et al. (1985). Over a
60-min selected period, a beat-by-beat time series of SAP and
pulse intervals were scanned. The objective of the method was to
search for sequences of at least four consecutive beats in which
increases in arterial pressure were followed by pulse interval
lengthening (up sequence) and decreases in arterial pressure were
followed by pulse interval shortening (down sequence). The slope
of the linear regression line between the SAP and pulse interval
was taken as the measure of spontaneous baroreflex sensitivity.
The baroreflex effectiveness index (BEI), which is complementary
information to the spontaneous baroreflex sensitivity, was also
calculated (Di Rienzo et al., 2001). The BEI is defined as the
ratio between the number of SAP ramps followed by reflex
pulse interval ramps and the total number of SAP ramps, either
accompanied by the corresponding reflex pulse interval ramps or
observed over a given time frame (Di Rienzo et al., 2001).
Morphological Analysis
After the hemodynamic recordings, the animals were
anesthetized with ketamine and xylazine (1:1; Ketamina
Agener União Saúde Animal, Embu-Guaçu, SP, Brazil; Dopaser
Hertape Calier Saúde Animal S/A, Juatuba, MG, Brazil). Then,
their entire hearts were harvested, rinsed using 10% KCl solution
to stop them in diastole, and they were then weighed. The hearts
were cut transversely and fixed in phosphate-buffered 10%
formalin for 24–48 h. For histological processing, the specimens
were embedded in paraffin and serially cut in 6-µm thick
slices. The sections were subsequently stained with picrosirius
red or hematoxylin and eosin. The analyses were performed
as described elsewhere in Durand et al. (2014) and Lataro
et al. (2013). Briefly, the heart picrosirius red-stained sections
were used to estimate the volume fraction (%) of collagen,
whereas 15 microscopic fields were randomly chosen and the
mean value was subsequently calculated. The minor diameter
of the myocytes of the left ventricle was measured in hearts
stained with hematoxylin and eosin, whereas approximately 30
microscopic fields were randomly chosen and the mean value
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was calculated. Since the myocardial fiber has a tubular shape,
the smallest axis is a measure perpendicular to the nucleus, no
matter the myocardial fiber is sectioned in longitudinal, oblique,
or transversal manner. These measurements were obtained from
the nuclear region of those cardiomyocytes where the nucleus
was centrally positioned. The sections were analyzed using the
video microscopy software Leica Qwin (Leica Imaging Systems,
Cambridge, UK) and the public-domain software NIH ImageJ
(developed by U.S. National Institutes of Health and available
at). Cardiac index (mg/g) was calculated by ratio heart weight
(mg) on body weight (g).
Group Sizes and Blinding
Experiments were carried out in 5 independent experiments
from WT and ELA-2 KO mice. In both groups it was also
measured the arterial pressure and heart rate combined with the
evaluation of hemodynamic (arterial pressure and pulse interval)
variability, symbolic analysis, spontaneous baroreflex sensitivity
and morphological analysis. While one investigator performed
echocardiographic experiments, another researcher blinded for
the experimental groups performed the analyses. The hearts were
collected after stopping in diastole and were kept in KCL (10%).
Therefore, the cardiac wall thickness was measured in diastole.
Statistical Analysis
Statistical analyses were performed using unpaired Student’s
t-test. Values are expressed as the mean± SEM. Differences were
considered significant at P < 0.05. All statistical analyses were
performed using GraphPad Prism Software.
RESULTS
Heart Rate and Arterial Pressure Variability
ELA-2KOmice showed a lower basal heart rate compared to WT
mice (Figure 1B), whereas there was no difference in the basal
mean arterial pressure (Figure 1A). Data from cardiovascular
variability analyses are shown in Table 1. ELA-2KOmice showed
reduced power (nu) for the LF band (Figure 2A), higher power
(nu) for the HF band (Figure 2B) and a lower LF/HF ratio
(Figure 2C). However, the SAP variability, SAP (Figure 3A)
and LF band (Figure 3B) were not different in ELA-2KO mice
compared to WT mice.
Data from symbolic analysis, a tool that also evaluates
sympathetic and parasympathetic cardiac modulation (Guzzetti
et al., 2005b; Porta et al., 2007), are shown in Figure 4. The 0
V pattern occurrence, which indicates cardiac sympathetic
modulation, was similar between ELA-2 KO and WT
mice (Figure 4A). Furthermore, cardiac parasympathetic
modulation, assessed by 2 LV pattern occurrence, was
higher in ELA-2KO than WT mice (Figure 4C). The
sympathetic and parasympathetic modulation assessed by 1
V pattern occurrence, was higher in ELA-2KO than WT mice
(Figure 4B). Nevertheless, 2 UV pattern occurrence, which in
healthy subjects seems to be under vagal control (Tobaldini
et al., 2009), was similar between ELA-2KO and WT mice
(Figure 4D).
FIGURE 1 | Basal mean arterial pressure (A) and heart rate (B) from WT
(n = 5) and ELA-2KO (n = 6) mice. WT, wild C57Bl mice; ELA-2KO, elastase-2
knockout mice. Values are presented as the mean ± SEM. *p < 0.05
compared with WT.
TABLE 1 | Pulse interval (PI) and systolic arterial pressure (SAP) variability
from wild type (WT) and knockout mice for tissue enzyme elastase-2
(ELA-2KO).
WT ELA-2 KO p-value
PULSE INTERVAL VARIABILITY
SDNN, ms 7.1 ± 1.3 5.8 ± 1.3 0.522
RMSSD, ms 7.4 ± 1.4 6.3 ± 1.4 0.593
VLF, ms 21.2 ± 5.6 12 ± 3.4 0.200
LF, ms2 22.6 ± 14.8 17.4 ± 9.6 0.724
HF, ms2 13.4 ± 3.5 23.1 ± 8.5 0.319
LF, nu 51.8 ± 4.8 33.6 ± 5.0 0.032
HF, nu 48.2 ± 4.8 66.4 ± 5.0 0.032
LF/HF 1.45 ± 0.3 0.6 ± 0.1 0.039
SYSTOLIC ARTERIAL PRESSURE VARIABILITY
SDNN, mmHg 3.6 ± 0.3 3.5 ± 0.6 0.975
LF, mmHg2 11.6 ± 4.3 6.9 ± 1.8 0.343
SDNN, standard deviation of successive normal values; RMSSD, square root of the
mean of the sum of the square of differences between adjacent pulse intervals; LF, low
frequency; HF, high frequency; nu, normalized units. Data are presented as mean , SEM,
WT-n = 5, ELA-2 KO n = 6. Bold values means p < 0.05 compare with WT.
Spontaneous Baroreflex Sensitivity
ELA-2KO mice did not show alteration of the spontaneous
baroreflex sensitivity indices, i.e., gain and BEI (Figures 5A,B).
Cardiac Function and Remodeling
The assessment of cardiac function showed that the heart rate
under anesthesia was reduced in ELA2KO mice compared to
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FIGURE 2 | Spectral power density of heart rate, in normalized units
(nu), for (A) low-frequency (LF) and (B) high-frequency (HF) bands, and (C)
LF/HF from WT (n = 5) and ELA-2KO (n = 6) mice. WT, wild C57Bl mice;
ELA-2KO, elastase-2 knockout mice. Values are presented as the mean ±
SEM. *p < 0.05 compared to WT.
WT (388 ± 16 vs. 438 ± 4.8 bpm from WT). The assessment
of cardiac function showed that the heart rate under anesthesia
was reduced in ELA2KO mice compared to WT (388 ± 16
vs. 438 ± 4.8 bpm from WT, p = 0.025) mice, whereas the
ejection fraction and fractional shortening were similar between
ELA-2KO and WT mice (Figures 6A,B). For the left ventricle
dimensions, ELA-2KO mice showed smaller diameters than WT
mice (Figures 6C,D). Indeed, ELA-2KO mice showed smaller
left ventricles than WT mice, despite similar heart (138.5 ± 8.2
vs. 129.9 ± 2.4mg from WT) and body weights (29.1 ± 1.0 vs.
29.0 ± 0.5 g from WT). Cardiac output and stroke volume were
lower in ELA-2KO than WT mice (Figures 6E,F). As shown by
echocardiography, ELA-2KO mice showed significantly smaller
left and right ventricle areas than WT mice (Figures 7A,B).
Nonetheless, no differences in the left and right ventricle
wall thickness were observed (Figures 7C,D). For the septum
thickness and cardiac index, ELA-2KO mice did not show
alterations compared to WT mice (Figures 7E,F). Furthermore,
FIGURE 3 | Systolic arterial pressure (A) and spectral power density of
systolic arterial (B) pressure, in absolute units (abs), for low-frequency (LF)
bands from WT (n = 5) and ELA-2KO (n = 6) mice. WT, wild-type C57Bl mice;
ELA-2KO, elastase-2 knockout mice. Values are presented as the mean ±
SEM.
the myocyte size and collagen density were similar in ELA-2KO
and WT mice (Figure 8). Histological analysis confirmed the
morphological alteration of hearts from ELA-2KO mice.
DISCUSSION
This is the first study in vivo describing that ELA-2 KO
mouse and ELA-2 acts on the sympathovagal balance of
the heart of ELA-2KO mice. The important finding was the
significant alteration in the cardiac sympathovagal balance,
characterized by increased parasympathetic and reduced
sympathetic modulation. The lower heart rate, cardiac output,
stroke volume, and reduced left ventricle are also interesting
findings that may be related to autonomic dysregulation or
associated with overall systemic change. Nevertheless, these
findings provide the first evidence that ELA-2 plays a role
in the maintenance of basal hemodynamics, contributing to
cardiovascular homeostasis.
ELA-2 belongs to the chymotrypsin-like elastase family,
member 2A. Ela-2 is considered the only representative of
this family of proteases that is secreted outside the digestive
tract and is involved in Ang II generation. ELA-2 is widely
found in several organs such as lung, pancreas, liver, blood
vessels (mesenteric, and carotid arteries), heart and kidney of
rodents (Santos et al., 2003; Becari et al., 2005, 2011). The
importance of this functional alternative pathway for Ang II
generation was demonstrated in heart, carotid and mesenteric
arteries from normotensive and spontaneously hypertensive
(SHR) rats (Santos et al., 2002, 2003; Becari et al., 2005,
2011).
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FIGURE 4 | Symbolic analysis from WT and ELA-2KO mice. (A) 0V: three symbols equal indicate sympathetic modulation; (B) 1V: one variation, two symbols
equal and one different, indicate both sympathetic and parasympathetic modulation; (C) 2LV: two like variations indicate parasympathetic modulation; (D) 2UV: two
unlike variations indicate parasympathetic modulation. WT, wild C57Bl mice; ELA-2KO, elastase-2 knockout mice. Values are presented as the mean ± SEM. *p <
0.05 compared to WT (n = 5–6).
ELA-2KO mice presented a reduced heart rate with
normal systemic arterial pressure. The ELA-2 deficiency
could possibly decrease the cardiac inhibitory effect of Ang II
on parasympathetic function, justifying the observed relative
bradycardia in ELA-2KO mice. Ang II can enhance the
sympathetic tone and facilitate catecholamine release from
cardiac sympathetic nerve endings via AT1R (Reid, 1992; Brasch
et al., 1993; Bezerra et al., 2001). By contrast, Takata et al.
(2004) demonstrated that inhibition of ACE with captopril
enhanced vagal nerve stimulation-evoked bradycardia in pithed
rats, without affecting cardiac sympathetic neurotransmission.
Furthermore, ELA-2 is a serine proteinase with broad substrate
specificity; therefore, it may play important role on different
systems other than the renin angiotensin system (RAS). Because
the autonomic and morphological changes in ELA-2 KO mice
are qualitatively and quantitatively different when RAS is simply
inhibited, the hypothesis that the inhibition of Ang II is not the
main or, at least, the only factor responsible for the physiological
changes seen in ELA-2 KO mice is supported.
The main morphological finding shown by echocardiography
was an apparent hypoplasic left ventricle in ELA-2KO mice
combined with reduced stroke volume and cardiac output,
despite no changes in body and heart weights or cardiac index.
These morphological findings were confirmed histologically by
significant reduction of the ventricles. Interestingly, there was
no alteration of ventricular and septal wall thickness, myocyte
diameter and collagen concentration.
The reduced cardiac output may be explained by the
association of bradycardia and low stroke volume. Furthermore,
FIGURE 5 | Spontaneous baroreflex sensitivity: (A) gain and (B) baroreflex
effectiveness index (BEI) for WT (n = 5) and ELA-2KO (n = 6) mice. WT, wild
C57Bl mice; ELA-2KO, elastase-2 knockout mice. Values are presented as the
mean ± SEM.
the basal arterial pressure demonstrated a trend to increase (p
= 0.07), likely due to an increase in the peripheral resistance.
Indeed, unpublished data from our group demonstrated
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FIGURE 6 | Echocardiography from WT (n = 5) and ELA-2 KO (n = 5) mice. Cardiac function assessment: (A) ejection fraction; (B) fractional shortening, (C)
LVIDd (end diastolic left ventricular internal diameter); (D) LVIDs (end systolic left ventricular internal diameter); (E) cardiac output; (F) stroke volume. WT, wild C57Bl
mice; ELA-2KO, elastase-2 knockout mice. Values are presented as the mean ± SEM. *p < 0.05 compared to WT.
increased vascular resistance in this mouse strain. We recently
investigated the importance of assessing local Ang II generation
in peripheral resistance arteries on myocardial infarction. The
fact that Ang II generation is increased and ELA-2 is responsible
for Ang II generation in mesenteric resistance arteries from
mice submitted to myocardial infarction, these findings provide
novel information for the role played by ELA-2 upon vascular
resistance in this pathological condition (Becari et al., 2017).
Heart rate and arterial pressure variability are extensively
used to assess autonomic modulation of the cardiovascular
system under clinical (Huikuri and Stein, 2013; Stein, 2013;
Wu et al., 2014) and experimental conditions (Mansier et al.,
1996; Wickman et al., 1998; Sabino et al., 2013). In the
current study, the SAP variability in the time and frequency
domains was similar between ELA-2KO andWTmice. However,
the LF power of the pulse interval spectrum and LF/HF
ratio were reduced, whereas the HF was increased in ELA-
2KO mice, indicating a sympathovagal balance with a shift
toward parasympathetic modulation of the heart. Clinical and
experimental studies that evaluated heart rate variability after
inhibition of ACE in cardiovascular disease also led to an increase
in HF oscillations and decrease in both LF oscillations and
the LF/HF ratio (Menezes et al., 2004; Albarwani et al., 2013;
Chompoosan et al., 2014). These data indicate that the prevailing
sympathetic drive observed in cardiovascular diseases can be
blunted by ACE inhibition and its consequent reduction of Ang
II availability. The results from symbolic analysis demonstrated
an increase in 2 LV pattern occurrence, with no changes
in 0 V and 2 UV in ELA2KO mice. Notably, according to
studies that used these nonlinear normalized indices, the 1 V
pattern occurrence represents parasympathetic and sympathetic
modulation, whereas the 2 UV pattern occurrence represents
only parasympathetic modulation of the heart (Porta et al.,
2007; Durand et al., 2015). Collectively, the data from spectral
and symbolic analysis suggest that ELA2KO mice have a shift
toward parasympathetic over sympathetic modulation of the
heart, which likely contributed to the basal bradycardia exhibited
by these mice.
An approach for estimating spontaneous baroreflex sensitivity
is a dynamic evaluation called the sequence technique (Bertinieri
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FIGURE 7 | Histological analysis of the left ventricle from WT (n = 5) and KO ELA-2 (n = 6) mice. Bar graphs show the following: (A) left ventricular area; (B)
right ventricular area; (C) left ventricular wall thickness; (D) right ventricular wall thickness; (E) septum thickness; (F) cardiac index. WT, wild C57Bl mice; ELA-2KO,
elastase-2 knockout mice. Values are presented as the mean ± SEM. **p < 0.01 compared to WT.
et al., 1985), and it has also been applied to conscious mice
(Joaquim et al., 2004; Chen et al., 2005). Laude et al. (2008)
showed that the spontaneous baroreflex sensitivity obtained
through the sequence technique was highly correlated with
spectral estimates and also demonstrated a vagal predominance
on baroreflex control of heart rate in conscious mice. The results
from our laboratory in conscious mice (Fazan et al., 2005)
showed that baroreflex modulation of PI plays a role in the
LF band, but not in the HF band of PI variability, mediated
by both sympathetic and parasympathetic drives. Nevertheless,
in the present study, a difference in baroreflex sensitivity was
not observed between groups, suggesting that the increased
parasympathetic modulation in ELA-2KO mice is not due to
baroreflex sensitivity enhancement.
The deletion of ELA-2 in mice decreased basal heart rate and
stroke volume, these observations suggest that ELA-2 plays a role
in maintaining cardiac heart rate and contractility. Additionally,
the reduced heart rate, cardiac output, stroke volume, and
reduced left ventricle size are also interesting findings that might
be related to the autonomic dysregulation, or associated with
overall systemic change. These data indicate that ELA-2 may
play a role on basal cardiac function and peripheral resistance.
Increased peripheral resistance, a hallmark of chronic heart
failure after myocardial infarction (Schrier and Abraham, 1999)
has been primarily attributed to neurohumoral pathways and
may involve both the RAS and the sympathetic nervous system
(Zelis and Flaim, 1982; Gschwend et al., 2003). The increased
vascular resistance is considered a compensatory mechanism to
maintain organ perfusion by sustaining blood pressure in a failing
heart. Increased vasoconstriction appears to be tightly linked to
increased levels of local Ang II or constitutive upregulation of the
AT1R. The fact that Ang II generation is increased and ELA-2 is
responsible for Ang II generation inmesenteric resistance arteries
from mice submitted to myocardial infarction, these findings
provide novel information for the role played by ELA-2 upon
vascular resistance in this pathological condition.
The increased parasympathetic and decreased sympathetic
modulation of the heart in ELA-2KO mice may have determined
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FIGURE 8 | Histological analysis of the left ventricle from WT (n = 5) and KO ELA-2 (n = 6) mice. (A): hematoxylin and eosin staining illustrates the myocyte
diameter (scale bar = 50µm). (B): picrosirius red staining illustrates the collagen density (scale bar = 50µm). (C): myocyte diameter from the left ventricle. (D):
collagen fraction from the left ventricle. WT, wild C57Bl mice; ELA-2KO, elastase-2 knockout mice.
chronotropic and inotropic attenuation, which may affect the
cardiac output, stroke volume and left ventricular dimension.
Ang II exerts direct positive chronotropic and inotropic effects
(Beaulieu and Lambert, 1998; Patil et al., 2011). Studies
performed in mice overexpressing ACE in the cardiac tissue
demonstrated that increased Ang II generation produced a
mouse phenotype with cardiac electrical abnormalities associated
with a high incidence of sudden death (Xiao et al., 2004;
Kasi et al., 2007). By overexpressing ACE only in the hearts
of mice, Xiao et al. (2004) observed an enlargement of
the atrial area without ventricular alterations, but remarkable
cardiac arrhythmia and an incidence of sudden death. These
authors concluded that Ang II produced by ACE does not
necessarily promote ventricular enlargement or dysfunction, but
can cause abnormal cardiac electrical activity. In the current
study, the deletion of ELA-2 reduced both basal chrono- and
inotropism, leading to a decrease in basal heart rate and stroke
volume. These findings indicate that ELA-2 in cardiac tissue
may play a role in maintaining basal heart rate and cardiac
contractility.
Some limitations of this study should be acknowledged.
First, it is not clear whether these autonomic and morphologic
changes are specifically due to a reduction in local or
circulating Ang II generation or due to another unknown
mechanism driven by ELA-2 deficiency. Second, ACE inhibitors
or angiotensin receptor antagonists were not used in the
experiments. This pharmacological approach could provide
more information regarding the participation of Ang II in
ELA-2KO.
In summary, the present study provides direct evidence that
ELA-2 has a functional role in cardiocirculatory regulation
under physiological conditions in mice. The deletion of ELA-
2 resulted in a decrease in basal heart rate and stroke volume,
indicating that ELA-2 from the heart may play a role in
maintaining the basal heart rate and cardiac contractility. These
data indicate that ELA-2 may play a role in basal cardiac function
and peripheral resistance by itself through cardiac autonomic
modulation.
CONCLUSION
These results provide the first evidence that ELA-2 modulates the
sympathovagal balance in the heartsmice, as demonstrated by the
reduced sympathetic modulation of the heart rate in ELA-2KO
animals.
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